# FDA Inspection 1030263 - Elysium Pharmaceuticals Limited - September 08, 2017

Source: https://www.keypedia.com/records/fda_inspections/elysium-pharmaceuticals-limited/e8c50dc8-389c-4877-bd8c-54c6defb7467
Source feed: FDA_Inspections

> FDA Inspection 1030263 for Elysium Pharmaceuticals Limited on September 08, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030263
- Company Name: Elysium Pharmaceuticals Limited
- Inspection Date: 2017-09-08
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1195116 - 2023-01-16](https://www.keypedia.com/records/fda_inspections/elysium-pharmaceuticals-limited/9ed57172-98d1-404f-9159-be89805611dd)
- [FDA Inspection 911280 - 2014-12-26](https://www.keypedia.com/records/fda_inspections/elysium-pharmaceuticals-limited/9aa95820-391c-4a22-9f73-b62b9adad617)

Company: https://www.keypedia.com/companies/elysium-pharmaceuticals-limited/6249fc41-1206-431f-87ee-b7b13c89e8f4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c